ADAP Advocacy Releases Data Visualizing 340B Drug Pricing Program Trends

What Happened

ADAP Advocacy has introduced a new infographic examining the current state of the federal 340B Drug Pricing Program. The visual summary accompanies the organization's ongoing campaign, which scrutinizes the program's rapid financial expansion.

Data within the infographic tracks the program's massive scale, noting that annual purchases exceeded $100 billion in 2025. The project highlights a disconnect between this growth and the actual delivery of patient-centered services.

The release specifically calls attention to the widening gap between institutional revenue and community benefits. It serves as a resource for stakeholders interested in the intersection of federal healthcare policy and actual patient outcomes.

The Core Points

Infographic visualizes the scale of the 340B Drug Pricing Program
Highlights stagnant charity care levels despite massive industry growth
Documents 2025 purchase volume exceeding $100 billion
Criticizes rising executive pay alongside increasing patient medical debt
Continues the 340B Too Big To Fail national advocacy campaign

Context in 60 Seconds

The 340B program was originally designed to stretch federal resources to help safety-net providers care for vulnerable populations. However, as the program has ballooned into a $100 billion industry involving tens of thousands of entities, critics have raised concerns about whether the financial benefits are reaching patients as intended.

Broadly, this reflects a tension in the healthcare sector where administrative and institutional growth often outpaces measurable improvements in charity care. As medical debt rises and executive compensation packages increase, advocacy groups are pushing for greater transparency and accountability within federally subsidized systems.

Bottom Line

The new infographic underscores a growing skepticism regarding the effectiveness of the 340B program, pointing to a decline in charity care despite significant financial growth.

Loading briefing details...